Proteoliposome derived cochleate as novel adjuvant

Bracho, G; Lastre, M; del Campo, J; Zayas, C; Gonzalez, D; Gil, D; Acevedo, R; Taboada, C; Solis, RL; Perez, O

Abstract

Cochleate structures (CS) consist in a highly stable lipid structures that have been reported to be a good antigen delivery system. The incorporation of pathogen associated molecular pattern (PAMP) from bacterial membranes into CS became in a promising approach to develop adjuvants, particularly mucosal adjuvants. Therefore, we prepare CS from proteoliposome (PL) obtained from Neisseria meningitidis B (PLCS) and evaluated it for its capability to stimulate the immune system as well as the adjuvant activity. The ability of PLCS to induce Th 1 polarization was also explored. The results and the easy capability for new antigen incorporation on CS support its use as adjuvant for immunization with a large variety of pathogen derived antigens and different routes of immunization. (c) 2005 Elsevier Ltd. All rights reserved.

Más información

Título según WOS: ID WOS:000237027100010 Not found in local WOS DB
Título de la Revista: VACCINE
Volumen: 24
Editorial: ELSEVIER SCI LTD
Fecha de publicación: 2006
Página de inicio: S30
Página final: S31
DOI:

10.1016/j.vaccine.2005.01.108

Notas: ISI